Repare Therapeutics

Repare Therapeutics develops precision oncology therapeutics using a synthetic lethality-based approach.

1 documented relationship

Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount.

Detailed register

Katina DortonEmploymentRepare Therapeutics
^{2Mallinckrodt Announces Board of Directors and Leadership Updatesbiospace.com}^{3Katina Dorton - 30th Annual Stanford Directors' Collegeconferences.law.stanford.edu}
Position or object indicated by the source: “CFO”.

Sources

1.
Repare Therapeutics | Synthetic Lethality Precision Oncology
Web pagereparerx.com
View original ↑ Back to text
2.
Mallinckrodt Announces Board of Directors and Leadership Updates
Web pagebiospace.com
View original ↑ Back to text
3.
Katina Dorton - 30th Annual Stanford Directors' College
Web pageconferences.law.stanford.edu
View original ↑ Back to text